FDA Advisory Committee to review SYD-101 for pediatric myopia October 30ByJordana JoySeptember 24th 2026The meeting will include an Open Public Hearing.
FDA accepts NDA for bimatoprost grenod in open-angle glaucoma and OHTByJordana JoyAugust 27th 2026The agency assigned a PDUFA target action date of April 30, 2027.